Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search help
44 results
  1. Results - Treatment of Nonmetastatic Muscle-Invasive Bladder Cancer - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK310449
    ... an additional two cycles of the first chemotherapy regimen; from 2003-2007, chemotherapy with paclitaxel, gemcitabine, and cisplatin for two cycles, followed by intensity-modulated radiation ...
  2. Cartilage (Bovine and Shark) (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65762
    ... therapy; participating centers used one of two chemotherapy regimens, either carboplatin and paclitaxel, or cisplatin and vinorelbine. No statistically significant difference in overall ...
  3. Childhood Extracranial Germ Cell Tumors Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65877
    ... their first regimen of chemotherapy. The conventional chemotherapy regimen includes four cycles of the drugs paclitaxel, ifosfamide, and cisplatin. The HD treatment includes two cycles of paclitaxel ...
  4. Gestational Trophoblastic Disease Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65977
    ... 2 ] [Level of evidence: 3iiiDii] A variety of regimens have been reported that include combinations of the following:[ 3 - 7 ] Cisplatin. Etoposide. Bleomycin. Ifosfamide. Paclitaxel. Fluorouracil. Floxuridine. A select group of patients with ...
  5. Systemic Therapy - Diagnosis and Management of Metastatic Malignant Disease of Unknown Primary Origin - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK82144
    ... Site - A Randomized Study of 2 Combination Chemotherapy Regimens. European Journal of Cancer & Clinical Oncology. 1987; 23 (11):1645–8. [ PubMed : 2448145 ] Moller AKH, Damgaard K, Nelausen K, Daugaard G. Paclitaxel, cisplatin and gemcitabine in the treatment of carcinomas of ...
  6. Anal Cancer Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65778
    ... events were more common in patients treated with cisplatin plus 5-FU (62% vs. ... Other chemotherapy regimens, such as modified docetaxel, cisplatin, and 5-FU, ...
  7. NLM Digital Collections - Poly ADP-ribose polymerase (PARP) inhibitors for ovarian cancer : effectiveness and value : ... 
    Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, September 28, 2017
    resource.nlm.nih.gov/101723925
    ... postoperative/adjuvant therapy with a platinum (e.g., cisplatin, carboplatin) and a taxane agent (e.g., paclitaxel, docetaxel) or liposomal doxorubicin.7-9 For recurrence, several chemotherapy regimens (e.g., docetaxel, paclitaxel, gemcitabine, liposomal doxorubicin, topotecan ...
  8. What is the expected value of perfect information in reducing uncertainty surrounding the cost-effectiveness of ... 
    https://www.ncbi.nlm.nih.gov/books/NBK82153
    ... nationally-agreed discounts were: 97% per dose for paclitaxel, 92% for carboplatin ... cost of each regimen was calculated for England and for Wales. The ...
  9. Breast Cancer Treatment (Adult) (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65744
    ... Taxanes. - Paclitaxel.[ 67 , 68 ] - Docetaxel. - Albumin-bound nanoparticle paclitaxel (ABI-007 or ... - Ixabepilone.[ 78 ] Combination regimens that have shown activity in metastatic breast cancer ...
  10. NLM Digital Collections - Management of lung cancer : a national clinical guideline 
    Publication: Edinburgh, Scotland : Scottish Intercollegiate Guidelines Network (SIGN), February 2014
    resource.nlm.nih.gov/101671102
    ... with advanced non-small cell lung cancer comparing paclitaxel-cisplatin- etoposide versus cisplatin- previously treated with platinum-containing chemotherapy etoposide as first-line treatment in patients with small-cell lung regimens. The TAX 320 Non-Small Cell Lung Cancer ...
first · previous · 1 · 2 · 3 · 4 · 5 · next · last